Selecteer een pagina

At first I didn’t have any interest for $STXS and it hasn’t been on any of my watch lists before. But during the day I regularly check the most percentage gainers of the day to see what moves. And look into the stocks to see if there is a possible play.

I saw $STXS up about 30-35% at that moment and started looking into it to find what the catalyst for this gain was.

Sadly I haven’t found any particular news or catalyst for that day. As mentioned in the latest news article about $STXS can be found here

Stereotaxis shares closed Friday up more than 73 percent with a volume surpassing 17 million. There was no specific news that might have prompted the activity, nor has there been since Monday, when the firm announced it was granted 510k clearance by the Food and Drug Administration to market its Vdrive Robotic Navigation System with V-Sono Intracardiac Echocardiography catheter manipulator in the United States.

The only news that came out earlier was that it received FDA clearance.

Stereotaxis, Inc. (STXS) announced today that it has been granted 510(k) clearance by the Food and Drug Administration (FDA) to market its Vdrive(TM) Robotic Navigation System with V-Sono(TM) Intracardiac Echocardiography (ICE) catheter manipulator in the U.S. This represents the first FDA clearance for the Vdrive family of products, which has been utilized in Europe since 2011.

On this news the stock got up to $7 on Tuesday, all the way from below $2. But on Wednesday and Thursday the price started going down. And suddenly on Friday it started gaining again. Don’t really know why, so it was a though play, because you don’t know what to expect.

stxs_weekAlthough there was no real catalyst for this day, the price action was very good, as the volume was up high. So I started to look at what possible trades I could make in this one.



In total I made 73ct/share in only about an half hour of work. Great play!

It got much higher after I sold the second time as it looked like a hedge fund started buying into $STXS. Could have made so much more as the high of the day was at $8.99, would have been nice from my first buy at $5.75. But missed chance, I played it safe for myself and didn’t want to chase the stock to much by buying in for a third time.

Download the

CANSLIM Chart Book


You have Successfully Subscribed!